Current Health vs Reimagine Care (2026)
Both companies help cancer programs give CAR T and bispecific antibodies outside the hospital, and both sell a 24/7 clinical team rather than software alone. They watch the patient in different ways. Current Health starts from the body. An upper arm wearable streams vital signs continuously, models flag cytokine release syndrome hours before nurses usually see it, and ED and ICU nurses run neurotoxicity checks by video and escalate under each program's protocols. It also runs hospital at home programs and safety monitoring in drug trials, and its CAR T results come from peer reviewed studies at Mount Sinai and across Sarah Cannon's network. Reimagine Care starts from the conversation. Remi, its AI assistant, texts patients, scores their symptoms and either closes the exchange or hands it to oncology nurses and APPs, and its advanced therapy program adds home vital sign devices and daily video visits. It covers the wider cancer population too, from chemotherapy side effects to oral drugs, and reports its results as fewer ED visits. Current Health suits a program whose main worry is a fever or a fall in blood pressure in the hours after infusion; Reimagine Care suits a practice that wants one between visit service for all its cancer patients.
- Continuous vital signs from an FDA cleared upper arm wearable, with a temperature patch, blood pressure cuff and other devices added for each program.
- A CRS detection model tested at Mount Sinai, where it caught 18 of 20 episodes a median of seven hours before nurses recognized them.
- Hospital at home and drug trial safety monitoring from the same platform and nursing team.
- Two way integration with Epic, Cerner and Meditech, with SOC 2 Type 2 and ISO 27001 named.
- Support for every cancer patient between visits, not only those on advanced therapies, by text message with no app or portal.
- An AI assistant that closes routine symptom questions itself and passes the rest to oncology nurses and APPs with the conversation attached.
- Oral oncolytic management and treatment given at home, alongside CAR T and bispecific monitoring.
- A KPI model shown before signing, with part of the fee at risk for value based contracts.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Current Health and Reimagine Care are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Current Health | Reimagine Care |
|---|---|---|
| Primary category | Remote Monitoring & Chronic Care | Remote Monitoring & Chronic Care |
| Founded | 2014 | Not recorded |
| Headquarters | Boston, Massachusetts, United States | Nashville, Tennessee, United States |
| Website | currenthealth.com | reimaginecare.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached.
Current Health gives health systems, community oncology practices and drug makers the monitoring and nursing infrastructure to deliver CAR T and bispecific therapies outside the hospital and to run hospital at home programs. An FDA cleared upper arm wearable streams vital signs, models flag early cytokine release syndrome, and a 24/7 command center of ED and ICU nurses triages alarms, runs neurotoxicity checks by video and escalates to the treating team.
Source: AI Health Index, October 2026
Reimagine Care, owned by Cureety since September 2026, sells virtual oncology care to cancer centers, community practices and health plans. Remi, its AI assistant, texts patients in active treatment, scores their symptoms and either resolves the exchange or hands it to a 24/7 team of oncology APPs, nurses and medical assistants, and an advanced therapy program adds home vital sign monitoring for CAR T and bispecific patients.
Source: AI Health Index, October 2026
Questions buyers ask
How does each one catch cytokine release syndrome after infusion?
Current Health relies on continuous vital signs from its wearable and an axillary temperature patch, with models that flag early CRS; in a Mount Sinai study the best wearable model caught 18 of 20 episodes a median of seven hours before nurses did. Reimagine Care pairs home devices for temperature, heart rate, blood pressure and oxygen saturation with Remi's structured check ins, which ask about CRS and neurotoxicity symptoms and send red flags to its clinicians. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 12, 2026. No vendor pays for placement.
Who answers when something looks wrong?
Current Health's command center nurses, trained in emergency and intensive care and licensed in all 50 states, respond to alarms in a median of 2.3 minutes and escalate to the treating physician. Reimagine Care's APPs, nurses and medical assistants pick up escalations from Remi in about nine minutes on average, and Remi closes about half of all patient conversations without a person. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 12, 2026. No vendor pays for placement.
How is each paid for?
Neither publishes prices. Current Health prices care episodes through risk based or bundled arrangements and helps programs negotiate payer contracts. Reimagine Care sets fees per partner, shows the KPI model it will report against before signing, and puts part of its fee at risk for value based clients. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 12, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.
Reimagine Care has been owned by Cureety since September 2026, and Current Health was owned by Best Buy from 2021 until its founders bought it back in 2025. Neither company's detection or triage AI is FDA cleared: Current Health's CRS model is in an FDA early engagement program for home use devices, and Remi's symptom triage runs without a stated FDA pathway. Current Health names SOC 2 Type 2, ISO 13485 and ISO 27001, and Reimagine Care names no security certification.